These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28615035)

  • 41. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
    Demirci Y; Zhang B; Unver T
    J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spermatogenic Cell-Specific Gene Mutation in Mice via CRISPR-Cas9.
    Bai M; Liang D; Wang Y; Li Q; Wu Y; Li J
    J Genet Genomics; 2016 May; 43(5):289-96. PubMed ID: 27210043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem Cells.
    Chapman KM; Medrano GA; Jaichander P; Chaudhary J; Waits AE; Nobrega MA; Hotaling JM; Ober C; Hamra FK
    Cell Rep; 2015 Mar; 10(11):1828-35. PubMed ID: 25772367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.
    Bialk P; Sansbury B; Rivera-Torres N; Bloh K; Man D; Kmiec EB
    Sci Rep; 2016 Sep; 6():32681. PubMed ID: 27609304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of CRISPR-Cas9 in eye disease.
    Wu W; Tang L; D'Amore PA; Lei H
    Exp Eye Res; 2017 Aug; 161():116-123. PubMed ID: 28619505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
    Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
    J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CRISPR-Cas9 Targeted Mutagenesis Leads to Simultaneous Modification of Different Homoeologous Gene Copies in Polyploid Oilseed Rape (
    Braatz J; Harloff HJ; Mascher M; Stein N; Himmelbach A; Jung C
    Plant Physiol; 2017 Jun; 174(2):935-942. PubMed ID: 28584067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
    Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
    Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
    Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
    BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus).
    Aluru N; Karchner SI; Franks DG; Nacci D; Champlin D; Hahn ME
    Aquat Toxicol; 2015 Jan; 158():192-201. PubMed ID: 25481785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological plasticity rescues target activity in CRISPR knock outs.
    Smits AH; Ziebell F; Joberty G; Zinn N; Mueller WF; Clauder-Münster S; Eberhard D; Fälth Savitski M; Grandi P; Jakob P; Michon AM; Sun H; Tessmer K; Bürckstümmer T; Bantscheff M; Steinmetz LM; Drewes G; Huber W
    Nat Methods; 2019 Nov; 16(11):1087-1093. PubMed ID: 31659326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2.
    Humbert O; Laszlo GS; Sichel S; Ironside C; Haworth KG; Bates OM; Beddoe ME; Carrillo RR; Kiem HP; Walter RB
    Leukemia; 2019 Mar; 33(3):762-808. PubMed ID: 30291334
    [No Abstract]   [Full Text] [Related]  

  • 57. CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.
    Bagheri A; Culp PA; DuBridge RB; Chen TT
    Biochem Biophys Rep; 2022 Mar; 29():101205. PubMed ID: 35071801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulating gene regulation to treat genetic disorders.
    Matharu N; Ahituv N
    Nat Rev Drug Discov; 2020 Nov; 19(11):757-775. PubMed ID: 33020616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benchmarking: contexts and details matter.
    Zheng S
    Genome Biol; 2017 Jul; 18(1):129. PubMed ID: 28679434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two new CRISPR-generated alleles in the
    Horn C; Sholl R; Haskell D; Hebbar S; Zinovyeva A
    MicroPubl Biol; 2020 Apr; 2020():. PubMed ID: 32550512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.